Abstract
Experimental and clinical data suggest that activation of inflammation may occur after epileptic seizures without any evidence of systemic or central nervous system infection. Various animal and human studies have recently shown that cytokines are involved in the pathogenesis of epilepsy. Although little is known about the role of inflammation in epilepsy, it has been hypothesized that activated immune system and subsequent inflammatory reaction in the brain can intervene to facilitate certain molecular and structural changes occurring during and after seizure activity. This review focuses on the relationship between inflammation and epilepsy.
Keywords: blood-brain barrier, tumor necrosis factor alpha, Seizures, corticotropin releasing hormone, Temporal lobe epilepsy
Current Pediatric Reviews
Title: The Role of Inflammation in Epilepsy
Volume: 3 Issue: 4
Author(s): Alberto Verrotti, Giuseppe Latini, Alessandra Scardapane, Rossella Manco and Antonio Del Vecchio
Affiliation:
Keywords: blood-brain barrier, tumor necrosis factor alpha, Seizures, corticotropin releasing hormone, Temporal lobe epilepsy
Abstract: Experimental and clinical data suggest that activation of inflammation may occur after epileptic seizures without any evidence of systemic or central nervous system infection. Various animal and human studies have recently shown that cytokines are involved in the pathogenesis of epilepsy. Although little is known about the role of inflammation in epilepsy, it has been hypothesized that activated immune system and subsequent inflammatory reaction in the brain can intervene to facilitate certain molecular and structural changes occurring during and after seizure activity. This review focuses on the relationship between inflammation and epilepsy.
Export Options
About this article
Cite this article as:
Verrotti Alberto, Latini Giuseppe, Scardapane Alessandra, Manco Rossella and Vecchio Del Antonio, The Role of Inflammation in Epilepsy, Current Pediatric Reviews 2007; 3 (4) . https://dx.doi.org/10.2174/157339607782411538
DOI https://dx.doi.org/10.2174/157339607782411538 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nicotinic Receptor Mutant Mice in the Study of Autonomic Function
Current Drug Targets - CNS & Neurological Disorders Obituary
Mini-Reviews in Medicinal Chemistry Current Quest in Natural Bioactive Compounds for Alzheimer’s Disease: Multi-Targeted-Designed-Ligand Based Approach with Preclinical and Clinical Based Evidence
Current Drug Targets Role of Cation-Chloride-Cotransporters (CCC) in Pain and Hyperalgesia
Current Topics in Medicinal Chemistry NMDA Receptor Pharmacology: Perspectives from Molecular Biology
Current Drug Targets Role of Wnt Signaling in the Control of Adult Hippocampal Functioning in Health and Disease: Therapeutic Implications
Current Neuropharmacology Somatostatin sst4 Ligands: Chemistry and Pharmacology
Mini-Reviews in Medicinal Chemistry From A1 to A3 en passant Through A2A Receptors in the Hippocampus: Pharmacological Implications
CNS & Neurological Disorders - Drug Targets Adverse Reactions to Fluoroquinolones. An Overview on Mechanistic Aspects
Current Medicinal Chemistry Tau Pathology and Future Therapeutics
Current Alzheimer Research α7-Nicotinic Acetylcholine Receptors: An Old Actor for New Different Roles
Current Drug Targets Kynurenic Acid and Neuroprotective Activity of the Ketogenic Diet in the Eye
Current Medicinal Chemistry Variability of Biological Activities of Limonoids Derived from Plant Sources
Mini-Reviews in Organic Chemistry Structure-Affinity-Relationship Study of Bicyclic σ Receptor Ligands
Central Nervous System Agents in Medicinal Chemistry Symptomatic Treatment of Chronic Neuropathic Pain with Gabapentin Clinical Practice and Research Prospective
Current Neuropharmacology GABA System as a Target for New Drugs
Current Medicinal Chemistry Xenosensors CAR and PXR at Work: Impact on Statin Metabolism
Current Drug Metabolism A Focus on Pharmacological Management of Catecholaminergic Polymorphic Ventricular Tachycardia
Mini-Reviews in Medicinal Chemistry Clinical Trials for Neuroprotection in ALS
CNS & Neurological Disorders - Drug Targets Substituted Aminobenzothiazole Derivatives of Tacrine: Synthesis and Study on Learning and Memory Impairment in Scopolamine-Induced Model of Amnesia in Rat
Mini-Reviews in Medicinal Chemistry